Table 1 Patients’ clinical data

Age, mean ± SD (years)

53.12 ± 7.41

53.55 ± 12.75

45.13 ± 20.73

0.3013

Male/female ratio

3/14

6/5

6/2

N/A

CXR stage: 0/I/II/III/IV number of patients (n)

0/10/4/3/0

N/A

N/A

N/A

Tuberculosis examination negative/positive (n)

17/0

N/A

0/8

N/A

BMI (kg/m²)

24.74 ± 2.45

22.75 ± 3.87

22.87 ± 2.34

0.1564

SACE (IU/L)

58.47 ± 26.86 (n = 15)

N/A

N/A

N/A

ESR (mm/h)

24.13 ± 15.82 (n = 16)

31.20 ± 19.81 (n = 6)

34.57 ± 39.43 (n = 7)

0.5996

24-h urinary calcium

5.70 ± 2.11(n = 12)

N/A

N/A

N/A

CD3 (%)

66.56 ± 8.07 (n = 14)

N/A

58.67 ± 15. 58 (n = 7)

0.1380

CD4 (%)

34. 01 ± 10.15 (n = 14)

N/A

35.66 ± 13.03 (n = 7)

0.7526

CD8 (%)

24. 87 ± 10.40 (n = 14)

N/A

18.99 ± 4.51 (n = 7)

0.1730

IgG (ng/L)

12.36 ± 2.73 (n = 10)

N/A

14.67 ± 7.20

0.3607

IgA (ng/L)

1.96 ± 0.56 (n = 10)

N/A

2.73 ± 1.12

0.0734

IgM (ng/L)

1.47 ± 0.77 (n = 10)

N/A

1.19 ± 0.73

0.4324

C3 (ng/L)

1.25 ± 0.20 (n = 10)

N/A

1.20 ± 0.29

0.6584

C4 (ng/L)

0.31 ± 0.072 (n = 10)

N/A

0.34 ± 0.094

0.4571